Financial Performance - The company's operating revenue for 2024 reached approximately RMB 584.55 million, representing an increase of 11.30% compared to RMB 525.19 million in 2023[24]. - Net profit attributable to shareholders for 2024 was approximately RMB 85.87 million, a growth of 29.04% from RMB 66.54 million in 2023[25]. - Basic earnings per share for 2024 were RMB 0.76, reflecting a 31.03% increase from RMB 0.58 in 2023[24]. - The total amount for cash dividends and share repurchase is approximately 173.16 million CNY, accounting for 201.66% of the net profit attributable to shareholders for the year[5]. - The company achieved operating revenue of 584.55 million yuan in 2024, representing an 11.30% increase compared to 2023[196]. Cash Flow and Assets - The net cash flow from operating activities for 2024 was negative RMB 54.38 million, a significant decline compared to positive RMB 9.76 million in 2023, marking a decrease of 657.35%[25]. - As of the end of 2024, the total assets amounted to approximately RMB 2.13 billion, down 2.16% from RMB 2.17 billion at the end of 2023[25]. - The net assets attributable to shareholders decreased by 3.42% to approximately RMB 1.69 billion at the end of 2024, compared to RMB 1.75 billion at the end of 2023[25]. - Cash and cash equivalents decreased by 31.77% to CNY 852.37 million, primarily due to increased investments in financial products and long-term asset acquisitions[122]. - The company's accounts receivable increased by 73.32% to CNY 336.90 million, attributed to revenue growth and slower collection of sales payments[122]. Research and Development - Continuous investment in research and development for new technologies is a priority to maintain competitive advantage in the industry[16]. - The company's R&D expenditure accounted for 21.65% of operating revenue, a decrease of 0.71 percentage points compared to the previous year[26]. - R&D investment amounted to 126.57 million yuan, up 7.78% year-on-year, representing 21.65% of total revenue[41]. - The company has developed a core technology platform centered on ultrasonic technology, which includes six foundational R&D technologies, achieving international advanced levels in key innovations such as integrated wedge welding technology and ultrasonic metal welding quality monitoring technology[65]. - The company is focusing on expanding its ultrasonic technology applications in hydrogen energy, medical, and aerospace industries[75]. Market and Product Development - The company is focused on expanding its product offerings in ultrasonic technology, which is expected to drive future revenue growth[16]. - The automotive wire harness market is projected to reach approximately 376.3 billion yuan by 2026, indicating significant growth potential for the company's products[39]. - Revenue from the wire harness connector ultrasonic equipment business surged by 352.37% to 81.34 million yuan, driven by the growing demand in the automotive sector[39]. - The company launched new ultrasonic products for the new energy battery sector, including large-diameter wedge welding machines and CCS welding machines, which have received bulk orders[42]. - The company has established partnerships with major universities to enhance R&D capabilities and accelerate the commercialization of technological achievements[42]. Governance and Compliance - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[9]. - The company has not violated decision-making procedures for providing guarantees[9]. - The company has received a standard unqualified audit report from the accounting firm Rongcheng[4]. - The company has not experienced any changes in governance arrangements or other significant matters[7]. - The company has established a comprehensive internal control management system to ensure effective operation and compliance[200]. Shareholder and Remuneration Policies - The company plans to distribute a cash dividend of 3.50 CNY per 10 shares, totaling approximately 39.16 million CNY, which represents 45.61% of the net profit attributable to shareholders for 2024[5]. - The total remuneration for all directors, supervisors, and senior management at the end of the reporting period amounted to RMB 533.49 million[162]. - The company has a remuneration policy that considers regional and industry standards, as well as the company's actual situation[162]. - The remuneration for senior management is determined by the board of directors, while the remuneration for directors and supervisors is decided by the shareholders' meeting[161]. - The company has established a clear decision-making process for remuneration, ensuring transparency and accountability in its governance[161]. Risks and Challenges - The company has outlined potential risks in its report, advising investors to be cautious[8]. - The company faces risks related to high customer concentration and reliance on major clients, which could impact its business if product quality or performance does not meet client standards[86]. - The company anticipates that if it fails to innovate and meet market demands, its overall gross margin may decline due to competitive pressures and rising costs[89]. - The company has implemented strict internal controls to protect its core technologies, but risks of technology leakage still exist due to potential employee turnover[84]. - The company faced risks related to tax policy changes, which could adversely affect net profit if it fails to maintain its high-tech enterprise status[90].

法 律 意 见 书 苏同律证字（ 2025） 第 058 号 南 京 市 建 邺 区 贤 坤 路 江 岛 智 立 方 C 座 4 层 邮 编 ： 2 1 0 0 1 9 电话： + 8 6 2 5 - 8 3 3 0 4 4 8 0 传真： + 8 6 2 5 - 8 3 3 2 9 3 3 5 骄成超声限制性股票激励计划 法律意见书 关 于 上 海 骄 成 超 声 波 技 术 股 份 有 限 公 司 作 废 2023 年 、 2024 年 限 制 性 股 票 激 励 计 划 部 分 限 制 性 股 票 及 2024 年 限 制 性 股 票 激 励 计 划 首 次 授 予 部 分 第 一 个 归 属 期 归 属 条 件 成 就 之 江苏世纪同仁律师事务所 关于上海骄成超声波技术股份有限公司 作废 2023 年、2024 年限制性股票激励计划部分限制性股票 及 2024 年限制性股票激励计划首次授予部分第一个归属期 归属条件成就之法律意见书 致：上海骄成超声波技术股份有限公司 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民 共和国证券法》（以下简称"《证券法》"）、《上市公司股权激励管理办法 ...

往来情况专项说明 非经营性资金占用及其他关联资金 上海骄成超声波技术股份有限公司 容诚专字[2025]200Z0248号 ) 容诚会计师事务所(特殊普通合伙 中国·北京 容诚会计师事务所（特殊普通合伙） 总所：北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 1001-26 (100037) TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https://www.rsm.global/china/ 关于上海骄成超声波技术股份有限公司 非经营性资金占用及其他关联资金往来情况专项说明 容诚专字[2025]200Z0248号 上海骄成超声波技术股份有限公司全体股东 ： 我们接受委托，依据中国注册会计师审计准则审计了上海骄成超声波技术股 份有限公司（以下简称"骄成超声"）2024 年 12 月 31 日的合并及母公司资产负 债表，2024 年度的合并及母公司利润表、合并及母公司现金流量表和合并及母公 司所有者权益变动表以及财务报表附注，并于 2025 年 4 月 10 日出具了容诚审字 [2025]200Z0842 号的 ...

国泰海通证券股份有限公司 关于上海骄成超声波技术股份有限公司 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 上海骄成超声波技术股份有限公司（以下简称"骄成超声"或"公司"）首次公 开发行股票并上市持续督导保荐机构，根据《证券发行上市保荐业务管理办法》 《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求》《上海 证券交易所科创板股票上市规则》《上海证券交易所上市公司自律监管指引第11 号——持续督导》《上海证券交易所科创板上市公司自律监管指引第1号——规范 运作》等有关规定，对公司使用部分闲置募集资金进行现金管理的事项进行了核 查，具体情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意上海骄成超声波技术股份有限公司 首次公开发行股票注册的批复》（证监许可[2022]1547 号），公司首次向社会公开 发行人民币普通股(A 股)股票 2,050 万股，每股面值 1.00 元，发行价为每股人民 币 71.18 元。本次公开发行募集资金总额为人民币 1,459,190,000.00 元，扣除与 发行相关的费用人民币 162,827,815.69 元（不含增值税） ...

审计报告 上海骄成超声波技术股份有限公司 容诚审字[2025]200Z0842号 ) 容诚会计师事务所(特殊普通合伙 中国·北京 目 录 | 序号 | 内 容 | 页码 | | --- | --- | --- | | 1 | 审计报告 | 1-7 | | 2 | 合并资产负债表 | 1 | | 3 | 合并利润表 | 2 | | 4 | 合并现金流量表 | 3 | | 5 | 合并所有者权益变动表 | 4 | | 6 | 母公司资产负债表 | 5 | | 7 | 母公司利润表 | 6 | | 8 | 母公司现金流量表 | 7 | | 9 | 母公司所有者权益变动表 | 8 | | 10 | 财务报表附注 | 9-122 | 审 计 报 告 总所：北京市西城区阜成门外大街 22 号 1 幢 10 层 1001-1 至 1001-26 (100037) TEL:010-6600 1391 FAX:010-6600 1392 E-mail:bj@rsmchina.com.cn https://www.rsm.global/china/ 容诚审字[2025]200Z0842号 上海骄成超声波技术股份有限公司全体股东 ...

国泰海通证券股份有限公司关于 上海骄成超声波技术股份有限公司 2024 年度募集资金存放与使用情况的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 上海骄成超声波技术股份有限公司（以下简称"骄成超声"或"公司"）首次公 开发行股票并上市持续督导保荐机构，根据《证券发行上市保荐业务管理办法》 《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求》《上海 证券交易所科创板股票上市规则》《上海证券交易所上市公司自律监管指引第11 号——持续督导》《上海证券交易所科创板上市公司自律监管指引第1号——规范 运作》等有关规定，对骄成超声2024年度募集资金的存放和使用情况进行了核查， 具体情况如下： 一、募集资金基本情况 （一）募集资金到位情况 经中国证券监督管理委员会《关于同意上海骄成超声波技术股份有限公司首 次公开发行股票注册的批复》（证监许可〔2022〕1547号）核准，公司向社会公 开发行人民币普通股（A股）2,050.00万股，每股发行价为71.18元，共募集资金 总额为人民币145,919.00万元，根据有关规定扣除各项不含税的发行费用 16,282.78万元后，实际 ...

国泰海通证券股份有限公司 二、关联人基本情况和关联关系 关于上海骄成超声波技术股份有限公司 2025年度日常关联交易预计的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"或"保荐机构"）作为 上海骄成超声波技术股份有限公司（以下简称"骄成超声"或"公司"）首次公 开发行股票并上市持续督导保荐机构，根据《证券发行上市保荐业务管理办法》 《上海证券交易所科创板股票上市规则》《上海证券交易所上市公司自律监管指 引第 11号——持续督导》《上海证券交易所科创板上市公司自律监管指引第 1号 ——规范运作》等有关规定，对公司 2025 年度日常关联交易预计事项进行了核 查，具体情况如下： 一、日常关联交易基本情况 本次日常关联交易预计金额和类别如下： | | | | | | | 单位：万元 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 关联交易类 | | 本年度预 | 占同类业 | 本年年初至 3 月 31 日与关联 | 上年实 | 占同类业 | 本次预 | | 别 | 关联人 | 计金额 | 务比例 | | 际发生 | 务比例 | 计的原 | | ...

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.7600 | 0.5800 | 31.03 | 1.1100 | | 每股净资产（元） | 14.73 | 15.26 | -3.47 | 21.37 | | 每股公积金(元) | 12.98 | 12.89 | 0.7 | 18.27 | | 每股未分配利润(元) | 1.68 | 1.19 | 41.18 | 1.91 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 5.85 | 5.25 | 11.43 | 5.22 | | 净利润(亿元) | 0.86 | 0.67 | 28.36 | 1.11 | | 净资产收益率(%) | 5.06 | 3.83 | 32.11 | 15.37 | 前十大流通股东累计持有： 2870.23万股，累计占流通股比： 41.12%，较上期变化： -231.88万股。 | 名称 持有数量(万股) | | ...

Group 1 - Shanghai Jiao Cheng Ultrasonic Technology Co., Ltd. has obtained a patent for a "ultrasonic welding head assembly and welding device," with the authorization announcement number CN 222696247 U, applied on March 2024 [1] - The patent relates to ultrasonic welding technology, specifically involving a welding head assembly that includes a welding head body, a welding nozzle, and a connecting part, designed to enhance welding stability and efficiency [1] - The welding head body is structured to be twice or more the wavelength in length and operates in a full wave vibration mode at the resonant frequency, which improves the welding pressure range and structural rigidity [1] Group 2 - Shanghai Jiao Cheng Ultrasonic Technology Co., Ltd. was established in 2007 and is located in Shanghai, primarily engaged in general equipment manufacturing [2] - The company has a registered capital of 114.8 million RMB and a paid-in capital of 60.2 million RMB [2] - The company has invested in 11 enterprises, participated in 84 bidding projects, and holds 410 patents along with 23 trademark registrations [2]

上海骄成超声波技术股份有限公司 2024 年限制性股票激励计划预留授予激励对象名单 （预留授予日） 上海骄成超声波技术股份有限公司 2024 年限制性股票激励计划预留授予限 制性股票的分配情况如下： | 姓名 | 国籍 | 职务 | 获授限制性股 | 占预留授予限制 | 占预留授予时 | | --- | --- | --- | --- | --- | --- | | | | | 票数量(万股) | 性股票总数比例 | 股本总额比例 | | 技术及业务骨干人员（不超过 | | 人） 60 | 64.53 | 100.00% | 0.56% | 注：1、上述任何一名激励对象通过全部在有效期内的股权激励计划获授的本公司股票均未超过公司总 股本的 1%。公司全部有效期内的激励计划所涉及的标的股票总数累计不超过股权激励计划提交股东大会 审议时公司股本总额的 20%。 2、本激励计划激励对象不包括独立董事、监事、单独或合计持有上市公司 5%以上股份的股东、上市 公司实际控制人及其配偶、父母、子女。 上海骄成超声波技术股份有限公司董事会 2025 年 4 月 1 日 ...